F14.980 Cocaine use, unspecified with cocaine-induced anxiety disorder

Name of the Condition

• Cocaine use, unspecified with cocaine-induced anxiety disorder
• ICD-10 Code: F14.980

Summary

Cocaine use, unspecified with cocaine-induced anxiety disorder, describes cocaine use associated with anxiety symptoms directly caused by the drug. Cocaine, a potent stimulant, can disrupt neurotransmitter balance and trigger anxiety-related effects, which may manifest during or after use. This code applies when anxiety is the primary induced disorder and no other specific cocaine-induced condition is present.

Causes

The primary cause is the use of cocaine, which alters brain chemistry by increasing dopamine and norepinephrine levels. These changes can overstimulate the central nervous system, leading to anxiety symptoms. The disorder arises from the direct physiological effects of the drug rather than an underlying psychiatric condition.

Risk Factors

• Frequency of Use: Regular or heavy cocaine use increases the likelihood of developing induced anxiety.
• Method of Administration: Routes like smoking or injecting may intensify effects and associated risks.
• Polydrug Use: Combining cocaine with other substances can exacerbate or create unique induced conditions.
• Individual Susceptibility: Pre-existing anxiety or stress may amplify the drug's effects.

Symptoms

Symptoms include:

• Excessive worry or fear.
• Restlessness or agitation.
• Rapid heartbeat or palpitations.
• Shortness of breath or chest tightness.
• Tremors or muscle tension.
• Difficulty concentrating.

Diagnosis

Diagnosis involves evaluating patient history, including cocaine use patterns and symptom onset. Clinical assessment rules out other causes of anxiety, such as generalized anxiety disorder or panic disorder. Laboratory tests may confirm cocaine exposure, but symptoms must align temporally with drug use to attribute anxiety to cocaine.

Treatment Options

• Discontinuation of Cocaine Use: Essential to reduce anxiety symptoms.
• Cognitive Behavioral Therapy (CBT): Addresses substance use and anxiety management.
• Medications: Short-term use of anxiolytics may be considered under medical supervision.
• Supportive Care: Monitoring for withdrawal or acute anxiety episodes.

Prognosis and Follow-Up

Prognosis depends on the duration and severity of use. Early intervention improves outcomes, but relapse risk remains. Follow-up includes regular monitoring for substance use and anxiety symptoms, with adjustments to treatment as needed.

Complications

• Worsening anxiety or panic attacks.
• Cardiovascular issues (e.g., hypertension) from chronic use.
• Social or occupational impairment due to symptoms.
• Increased risk of other substance use disorders.

Lifestyle & Prevention

• Avoid cocaine use to prevent induced anxiety.
• Develop healthy coping mechanisms for stress.
• Seek support from mental health or substance use resources.
• Maintain a stable routine to reduce anxiety triggers.

When to Seek Professional Help

Seek help if anxiety symptoms are severe, persistent, or interfere with daily life. Immediate care is needed for acute symptoms like chest pain or difficulty breathing, which may indicate a medical emergency.

Tips for Medical Coders

Document the temporal relationship between cocaine use and anxiety symptoms to support the diagnosis. Ensure no other specified cocaine-induced disorder is present, as this code is for unspecified use with anxiety. Include details on symptom onset and duration for accurate coding.